Back to search

Article

Supply Chain Vulnerabilities in First-Line Treatments for Sexually Transmitted Infections: Implications for U.S. Public Health Preparedness

2026-05-07

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Objectives</h4> To evaluate supply-chain vulnerabilities affecting medications essential for treating sexually transmitted infection in the United States and identify disruption mechanisms that may predispose these therapies to shortages. <h4>Methods</h4> We conducted a qualitative, structured supply-chain vulnerability assessment of first-line medications for five priority sexually transm...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a83d8ceb-e98e-50c6-8ef0-bebf479535d1
DOI
10.64898/2026.05.06.26352546
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Supply Chain Vulnerabilities in First-Line Treatments for Sexually Transmitted Infections: Implications for U.S. Public Health PreparednessDOI 10.64898/2026.05.06.26352546
What Ails Drug Supply Chains? A Model for Diagnosis and Suggestions for a CureSemantic proximity
Analysis and Solutions for Drug Shortages in Multi-level Medical Institutions in China: References for Developing CountriesSemantic proximity
Risk Assessment and Management of Drug Inventory in Hospitals during COVID-19 Pandemic in TaiwanSemantic proximity
When Do Drug Shortages Raise Acquisition Costs? Average Duration Effects and Heterogeneous Price Pass-ThroughSemantic proximity
The Development, Implementation, and Application of a Probabilistic Risk Assessment Framework to Evaluate Supply Chain ShortagesSemantic proximity
The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?Semantic proximity
Closing the Loop: An Integrative Framework for Managing Unwanted Pharmaceuticals During COVID-19 and BeyondSemantic proximity
Microbiological Quality and Stability of Pharmaceutical Products in Europe: Discrepancies, Regulatory Perspectives and ChallengesSemantic proximity
Microbiological Quality and Stability of Pharmaceutical Products in Europe: Discrepancies, Regulatory Perspectives and ChallengesSemantic proximity
Impacts of the COVID-19 Pandemic on Healthcare Services in Malaysia from the Perspective of Healthcare Providers: A Cross-Sectional AnalysisSemantic proximity
From Supply Chain Risk to Systemwide Disruptions: Research Opportunities in Forecasting, Risk Management, and Product DesignSemantic proximity
Territorial inequities in access to essential medicines for neglected tropical diseases in a decentralised European health system: a nationwide assessment in SpainSemantic proximity
Select a neighboring publication to make it the new centre.